Abstract
Introduction
Spondylodiscitis is a combination of discitis and spondylitis. It is very rare to have an isolated discitis without associated vertebral osteomyelitis. It is relatively uncommon in developed nations. However, this disease can lead to severe disability and even death if left untreated. Antibiotics is the mainstay of treatment but cases with neurological compromise would need prompt surgical decompression and stabilisation. Recovery in serious cases is often a lengthy process, requiring long hospital stay. Our unit conducted a review as it is noted spondylodiscitis is becoming more common in elderly and immunocompromised groups.
Patients and methods
Retrospective study of spondylodiscitis presented to our unit over the last three years is conducted. Medical records and charts are reviewed, with a focus on disease presentation, risk factors, causative organisms and when surgery becomes necessary.
Results
61 cases are identified, average age 62. Lumbar vertebrae is the most affected region (36%), 15% showed multi-level involvement. Back pain presented in all cases. 75% have at least 1 risk factor. Micro-organisms isolated were Staphylococcus aureus (24.6%), coagulase negative staphylococci (9.8%), methicillin resistant S. Aureus (6.6%), Escherichia coli (6.6%) and mycobacterium tuberculosis (3.3%) and no organism found in 16.4%. 31% of cases required surgical intervention due to neurological deficit or vertebral collapse. 69% were managed conservatively The average inpatient stay was 50 days. CRP decreased as symptoms improve. There is no mortality in this series.
Conclusions
We noted a higher than usual presentation of spondylodiscitis in vulnerable patients in our region, often presented late. It is important to recognise this disease early. Once established, patients often require long hospital stay to control disease and regain mobilitiy, even when outpatient anti-biotic therapy is available. A multidisciplinary team approach would be beneficial for the recovery process.